Mastek Hits Tax Headwind: ₹124 Crore Dispute Looms

OTHER
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Mastek Hits Tax Headwind: ₹124 Crore Dispute Looms
Overview

Mastek faces a ₹123.58 crore tax assessment order for FY23, triggering penalty proceedings under Section 270A. The company is challenging the demand, citing computational errors, including miscalculated tax rates and denied credits, while maintaining no material financial impact.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

The Regulatory Challenge

The tax assessment order, dated May 30, 2026, represents a significant hurdle for Mastek, involving total additions of ₹123.58 crore for the 2023 fiscal year. This demand comprises a transfer pricing adjustment of ₹90.95 crore, initiated under Section 92CA(3) of the Income Tax Act, alongside a domestic tax addition of ₹32.63 crore. The initiation of penalty proceedings under Section 270A adds a layer of legal complexity, though the company’s history of managing tax litigations suggests a prepared defense strategy. Mastek has publicly contested the order, alleging systemic errors in the tax authority’s computation, specifically pointing to the denial of foreign tax credits and the exclusion of advance tax paid by a previously amalgamated subsidiary.

Financial Context and Market Reaction

This tax-related noise arrives at a sensitive time for Mastek, which has seen its share price fluctuate amidst a 24.5% decline over the past year. As of early June 2026, the stock trades near ₹1,682, maintaining a price-to-earnings (P/E) multiple of approximately 12.5x. While this valuation is significantly lower than the broader IT software industry median—often exceeding 23x—it reflects investor caution regarding the company’s recent margin compression. In the most recent quarter, EBITDA margins softened to 22.9% from 24.2%, hampered by wage inflation and strategic investments in AI-first service models. Despite the tax dispute, Mastek continues to prioritize liquidity, supported by a healthy balance sheet that remains virtually debt-free, a factor that distinguishes it from more leveraged mid-cap IT peers.

The Forensic Bear Case

The primary risk factor remains the company’s high revenue concentration in the UK public and healthcare sectors, which currently accounts for over 50% of its top-line. Any policy shift in UK government IT spending could severely impact Mastek’s growth trajectory, as evidenced by moderate revenue growth in recent quarters. Furthermore, while management expects no material impact from the current tax demand, penalty proceedings under Section 270A typically entail drawn-out litigation. Unlike larger industry incumbents like TCS or Infosys, which possess deeper capital reserves to weather protracted regulatory hurdles, Mastek’s smaller market capitalization leaves it more vulnerable to sentiment shifts driven by legal or tax-related headlines.

Future Outlook

Management is currently pivoting toward an AI-first business model to revitalize growth, having secured over 85 new AI-focused deals in FY26. With an order backlog exceeding ₹2,290 crore and a stable dividend policy—recently recommended at 320%—the company aims to maintain investor confidence. Brokerage sentiment remains split; while some maintain a hold rating citing strong execution track records, the overarching narrative is one of stock-specific risk management. Investors are watching for any acceleration in revenue conversion from the backlog to offset near-term operational headwinds and potential tax liabilities.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.